Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: 2020-12-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-21-000073
Form type
SC 13G
Filer
DISCOVERY CAPITAL MANAGEMENT, LLC / CT
CIK
CIK 1389507
Filed
Jan 07, 2021
Reporting period
Dec 28, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub